Mikyung Kelly Seo
5PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 07, 2024
Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?Anna Kenseth, Dominika Kantorova, Mikyung Kelly Seo
|Sep 02, 2021
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.Mikyung Kelly Seo, John Cairns
|Aug 20, 2021
A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper.Mikyung Kelly Seo, Mark Strong
|Jan 29, 2020
HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?Mikyung Kelly Seo, Oddbjørn Straume, Lars A Akslen
|Sep 27, 2018
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.Mikyung Kelly Seo, John Cairns
Pageof 1
